HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB:PWRM) announced today the filing of a US Patent application for the diagnosis of multiple forms of Alzheimer’s disease by monitoring a panel of protein biomarkers in human blood serum. This latest filing further extends the reach of the recently filed US Utility Patent Application that identified 47 protein biomarkers useful in the early diagnosis of Alzheimer’s disease.
